Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28996401 | 0.87 | ALDH1A1 (0.38) | ALDH1A1CYP3A4L3MBTL1TDP1LMNA | |
| SCHEMBL27254682 | 0.85 | ALDH1A1 (0.37) | ALDH1A1CYP3A4L3MBTL1TDP1LMNA | |
| SCHEMBL27254674 | 0.83 | ALDH1A1 (0.35) | ALDH1A1CYP3A4L3MBTL1TDP1LMNA | |
| SCHEMBL20036173 | 0.78 | ALDH1A1 (0.41) | ALDH1A1CYP3A4TDP1LMNATSHR | |
| SCHEMBL22339341 | 0.78 | LMNA (0.52) | ALDH1A1CYP3A4L3MBTL1TDP1LMNA | |
| SCHEMBL25493270 | 0.78 | LMNA (0.52) | ALDH1A1CYP3A4L3MBTL1TDP1LMNA | |
| SCHEMBL18484873 | 0.78 | LMNA (0.52) | ALDH1A1CYP3A4L3MBTL1TDP1LMNA | |
| SCHEMBL11589419 | 0.77 | CYP3A4 (0.40) | ALDH1A1CYP3A4L3MBTL1TDP1TSHR | |
| SCHEMBL19333630 | 0.76 | LMNA (0.50) | LMNATSHR | |
| SCHEMBL11891936 | 0.74 | ALDH1A1 (0.38) | ALDH1A1CYP3A4TDP1LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3434668-B1 | INDOLO-SUBSTITUTED-PIPERIDINE COMPOUNDS AS ESTROGEN RECEPTOR DEGRADING AGENT | LUOXIN PHARMACEUTICAL SHANGHAI CO LTD (CN) | 2020-08-26 | — | — | EP | disclosed |